Longbing Ling

808 total citations
28 papers, 663 citations indexed

About

Longbing Ling is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Longbing Ling has authored 28 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Longbing Ling's work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers) and Nanoplatforms for cancer theranostics (7 papers). Longbing Ling is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers) and Nanoplatforms for cancer theranostics (7 papers). Longbing Ling collaborates with scholars based in China, Bangladesh and Australia. Longbing Ling's co-authors include Xinsong Li, Yawei Du, Muhammad Ismail, Chen Yao, Qing Xia, Jianing Zhao, Yuan Du, Zhenglin Fu, Wenya Zhou and Wei He and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Langmuir.

In The Last Decade

Longbing Ling

26 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longbing Ling China 17 312 264 190 73 66 28 663
Birendra Chaurasiya China 17 274 0.9× 251 1.0× 182 1.0× 54 0.7× 162 2.5× 25 806
Sai Kiran S. S. Pindiprolu India 18 266 0.9× 216 0.8× 166 0.9× 62 0.8× 54 0.8× 40 692
Pallabita Chowdhury United States 18 332 1.1× 300 1.1× 253 1.3× 87 1.2× 97 1.5× 31 962
Venkateshwaran Krishnaswami India 15 173 0.6× 142 0.5× 137 0.7× 63 0.9× 125 1.9× 46 591
Robin Kumar India 13 307 1.0× 215 0.8× 232 1.2× 147 2.0× 40 0.6× 46 793
Shivani Saraf India 12 206 0.7× 199 0.8× 126 0.7× 35 0.5× 124 1.9× 27 497
Temidayo Olusanya United Kingdom 5 309 1.0× 282 1.1× 191 1.0× 62 0.8× 146 2.2× 6 671
Usamah Sayed Jordan 3 356 1.1× 284 1.1× 198 1.0× 59 0.8× 174 2.6× 4 818
Nayab Tahir Pakistan 10 225 0.7× 262 1.0× 166 0.9× 56 0.8× 218 3.3× 17 628
Ravi Prakash Shukla India 14 255 0.8× 200 0.8× 198 1.0× 89 1.2× 49 0.7× 39 613

Countries citing papers authored by Longbing Ling

Since Specialization
Citations

This map shows the geographic impact of Longbing Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longbing Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longbing Ling more than expected).

Fields of papers citing papers by Longbing Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longbing Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longbing Ling. The network helps show where Longbing Ling may publish in the future.

Co-authorship network of co-authors of Longbing Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Longbing Ling. A scholar is included among the top collaborators of Longbing Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longbing Ling. Longbing Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peng, Shengjun, Yizhou Wang, Zhifang Sun, et al.. (2023). Nanoparticles loaded with pharmacologically active plant-derived natural products: Biomedical applications and toxicity. Colloids and Surfaces B Biointerfaces. 225. 113214–113214. 22 indexed citations
3.
Zhu, Wei, Guangyao Lv, Min Liu, et al.. (2023). Pyridine-appended disulfidephospholipids enable exceptionally high drug loading and stability as a robust liposomal platform. Biomaterials Science. 11(14). 4822–4826. 2 indexed citations
4.
Zhao, Jianing, Jian Ruan, Guangyao Lv, et al.. (2022). Cell membrane-based biomimetic nanosystems for advanced drug delivery in cancer therapy: A comprehensive review. Colloids and Surfaces B Biointerfaces. 215. 112503–112503. 34 indexed citations
5.
Zhao, Jianing, Longbing Ling, Wei Zhu, et al.. (2022). M1/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis. Journal of Controlled Release. 353. 1068–1083. 63 indexed citations
6.
Zhao, Laien, Longbing Ling, Jing Lü, et al.. (2022). Reactive oxygen species‐responsive mitochondria‐targeted liposomal quercetin attenuates retinal ischemia–reperfusion injury via regulating SIRT1/FOXO3A and p38 MAPK signaling pathways. Bioengineering & Translational Medicine. 8(3). e10460–e10460. 36 indexed citations
7.
Ismail, Muhammad, Jianing Zhao, Yanping Zhu, et al.. (2021). ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis via inhibiting iRhom2/TNF-α/BAFF pathways. Nanoscale. 13(47). 20170–20185. 26 indexed citations
8.
Ling, Longbing, et al.. (2020). Vitamin E-based prodrug self-delivery for nanoformulated irinotecan with synergistic antitumor therapeutics. International Journal of Pharmaceutics. 577. 119049–119049. 20 indexed citations
9.
Ismail, Muhammad, Yawei Du, Longbing Ling, & Xinsong Li. (2019). Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria. International Journal of Pharmaceutics. 562. 162–171. 46 indexed citations
10.
Wang, Zhi, Longbing Ling, Yawei Du, Chen Yao, & Xinsong Li. (2019). Reduction responsive liposomes based on paclitaxel-ss-lysophospholipid with high drug loading for intracellular delivery. International Journal of Pharmaceutics. 564. 244–255. 37 indexed citations
11.
Ling, Longbing, Muhammad Ismail, Yawei Du, Chen Yao, & Xinsong Li. (2019). Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug. International Journal of Pharmaceutics. 560. 246–260. 25 indexed citations
12.
Du, Yawei, Longbing Ling, Muhammad Ismail, et al.. (2018). Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery. International Journal of Pharmaceutics. 549(1-2). 352–362. 49 indexed citations
13.
Ismail, Muhammad, Longbing Ling, Yawei Du, Chen Yao, & Xinsong Li. (2018). Liposomes of dimeric artesunate phospholipid: A combination of dimerization and self-assembly to combat malaria. Biomaterials. 163. 76–87. 67 indexed citations
14.
Fang, Shuo, Longbing Ling, Muhammad Ismail, et al.. (2018). Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy. Colloids and Surfaces B Biointerfaces. 166. 235–244. 24 indexed citations
15.
Yao, Chen, Longbing Ling, Yawei Du, et al.. (2017). Novel dual VES phospholipid self-assembled liposomes with an extremely high drug loading efficiency. Colloids and Surfaces B Biointerfaces. 156. 29–37. 9 indexed citations
16.
Lu, Lu, Yawei Du, Muhammad Ismail, et al.. (2017). Liposomes assembled from dimeric retinoic acid phospholipid with improved pharmacokinetic properties. European Journal of Pharmaceutical Sciences. 112. 186–194. 18 indexed citations
17.
Ling, Longbing, Yawei Du, Muhammad Ismail, et al.. (2017). Self-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapy. International Journal of Pharmaceutics. 526(1-2). 11–22. 31 indexed citations
18.
Du, Yawei, Wei Zhang, Muhammad Ismail, et al.. (2017). Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects. Bioorganic & Medicinal Chemistry. 25(12). 3247–3258. 36 indexed citations
19.
Ling, Longbing, et al.. (2017). Assembled Liposomes of Dual Podophyllotoxin Phospholipid: preparation, Characterization andIn VivoAnticancer Activity. Nanomedicine. 12(6). 657–672. 14 indexed citations
20.
Du, Yawei, et al.. (2017). Nanoformulation of dual bexarotene-tailed phospholipid conjugate with high drug loading. European Journal of Pharmaceutical Sciences. 100. 197–204. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Birendra Chaurasiya Breakdown of academic impact, for papers by Sai Kiran S. S. Pindiprolu Breakdown of academic impact, for papers by Pallabita Chowdhury Breakdown of academic impact, for papers by Venkateshwaran Krishnaswami Breakdown of academic impact, for papers by Robin Kumar Breakdown of academic impact, for papers by Shivani Saraf Breakdown of academic impact, for papers by Temidayo Olusanya Breakdown of academic impact, for papers by Usamah Sayed Breakdown of academic impact, for papers by Nayab Tahir Breakdown of academic impact, for papers by Ravi Prakash Shukla
Rankless by CCL
2026